AnaptysBio, Inc. (ANAB) vs Hemab Therapeutics Holdings, Inc. Common Stock (COAG)

A side-by-side comparison of AnaptysBio, Inc. and Hemab Therapeutics Holdings, Inc. Common Stock across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
AnaptysBio, Inc. logo
ANAB
AnaptysBio, Inc.
$1.42B
$47.89HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Hemab Therapeutics Holdings, Inc. Common Stock logo
COAG
Hemab Therapeutics Holdings, Inc. Common Stock
$1.33B
$28.37HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — ANAB vs COAG

growth of $100 · dividends reinvested · last 1y
ANAB -26.3% (-26.3%/yr)COAG -10.0% (-10.0%/yr)COAG compounded faster over this window
80100120140160Start $100$74$90
ANAB COAG

ANAB vs COAG: by the numbers

  • •ANAB is the larger company ($1.42B vs $1.33B market cap).
  • •ANAB is profitable (82.37% net margin) while COAG runs a net loss (0.00%).

Metrics side by side

Valuation

MetricANABCOAG
P/E ratio8.92N/A
P/S ratio5.97N/A
P/B ratio133.962.92
EV / EBITDA11.44N/A
FCF yield1.27%N/A

Profitability

MetricANABCOAG
Gross margin98.97%0.00%
Operating margin20.42%0.00%
Net margin82.37%0.00%
ROE1849.06%N/A
ROIC47.55%-38.09%

Growth (annualized)

MetricANABCOAG
Revenue CAGR (5Y)18.60%N/A
FCF CAGR (5Y)27.41%N/A
Total return CAGR (5Y)21.54%N/A

Frequently asked

Is ANAB or COAG more profitable?
ANAB runs the higher net margin — ANAB at 82.37% versus COAG at 0.00%.

Go deeper

Full ANAB analysisFull COAG analysisInteractive comparison tool

Dig into the metrics

AnaptysBio P/E ratioAnaptysBio ROEHemab Therapeutics Holdings, Inc. Common Stock ROEAnaptysBio operating marginHemab Therapeutics Holdings, Inc. Common Stock operating marginAnaptysBio revenue growthHemab Therapeutics Holdings, Inc. Common Stock revenue growthAnaptysBio free cash flowHemab Therapeutics Holdings, Inc. Common Stock free cash flow

AnaptysBio & Hemab Therapeutics Holdings, Inc. Common Stock appear in these rankings

Fastest Revenue Growth StocksHighest ROE StocksHighest ROIC StocksLowest P/E Ratio Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.